A single clonal origin of neoplastic B cells in a patient with CD5+B-intermediate lymphocytic lymphoma terminating in

M Abe1, K Tasaki, S Matsuda

  • 1Department of Pathology, Fukushima Medical College, Japan.

Insights

This study investigated a rare lymphoma case, finding both tumors originated from a single B cell clone. This offers insights into CD5+ B-lymphocyte differentiation pathways.

Area of Science:

  • Hematology
  • Oncology
  • Immunology

Background:

  • Investigating the clonal origin of CD5+ B-cell lymphomas is crucial for understanding their pathogenesis.
  • Plasmacytoid differentiation in intermediate lymphocytic lymphoma is a rare but significant event.

Observation:

  • Analyzed immunophenotype and immunoglobulin gene rearrangements in lymph node biopsies.
  • Both neoplasms exhibited the same kappa-light chain immunoglobulin type.
  • Identical immunoglobulin heavy and kappa-light chain gene rearrangements were detected in both neoplasms.

Findings:

  • The study suggests that both CD5+ B-intermediate lymphocytic lymphoma and its plasmacytoid differentiation derive from a single clonal B cell.
  • Demonstrated shared molecular markers confirming a uniclonal origin.

Implications:

  • This case provides valuable insights into the B-cell differentiation pathway, particularly in CD5+ lymphomas.
  • Understanding clonal evolution in lymphomas can inform diagnostic and therapeutic strategies.
  • Highlights the potential for B-cell lymphomas to undergo divergent differentiation from a common progenitor.